Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

English Pharmaceutical Industries

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000339 111 linked products · source seen 9 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx111product presentations
G46generic molecules
DF6dosage-form groups
TA9therapeutic areas
PKR111current price records
REG102registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage96%
priced packs safely normalized per unit
Comparable-market coverage91%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixEnglish Pharmaceutical IndustriesShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/english-pharmaceutical-industriesGenerated 9 Aug 2026Anti-infectives76 · 68%Gastrointestinal & hepatology12 · 11%Vitamins, minerals & nutrition7 · 6%Pain & musculoskeletal4 · 4%Fluids & supportive care4 · 4%Hematology & thrombosis3 · 3%CNS & mental health2 · 2%Other therapeutic areas3 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioEnglish Pharmaceutical IndustriesDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/english-pharmaceutical-industriesGenerated 9 Aug 2026111presentationsInjection59 · 53%Tablet24 · 22%Capsule12 · 11%Suspension9 · 8%Syrup5 · 5%Infusion2 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionEnglish Pharmaceutical IndustriesCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/english-pharmaceutical-industriesGenerated 9 Aug 2026101comparable productsBelow market median23 · 23%Near market median52 · 51%Above market median26 · 26%Company median price position0.0%Lowest-price equivalents11Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsEnglish Pharmaceutical IndustriesCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/english-pharmaceutical-industriesGenerated 9 Aug 2026Macter International Limited32 shared70% overlapZafa Pharmaceutical Laboratories (P…30 shared65% overlapBio-Labs(Pvt) Ltd30 shared65% overlapNabiqasim Industries (Pvt) Ltd.,28 shared61% overlapM/s. Genix Pharma (Pvt) Ltd.27 shared59% overlapMediate Pharmaceutical Pvt Ltd26 shared57% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives76 products · 68%
Gastrointestinal & hepatology12 products · 11%
Vitamins, minerals & nutrition7 products · 6%
Pain & musculoskeletal4 products · 4%
Fluids & supportive care4 products · 4%
Hematology & thrombosis3 products · 3%
CNS & mental health2 products · 2%
Cardiovascular2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Penicillin antibacterials18 products · 16%
Third-generation cephalosporins17 products · 15%
Fluoroquinolone antibacterials13 products · 12%
Antiemetics8 products · 7%
Antimalarials8 products · 7%
Vitamins / minerals / hematinics5 products · 5%
Analgesics / NSAIDs4 products · 4%
Aminoglycoside antibacterials4 products · 4%
Formulation footprint

Dosage forms

Injection59 products
Tablet24 products
Capsule12 products
Suspension9 products
Syrup5 products
Infusion2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 EnmoxAmoxicillin 8presentations 1000 mg, 125 mg/5 mL, 250 mg, 250 mg/5 mL · Tablet, Suspension, Injection #2 ChroncefCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #3 EngsitOndansetron 7presentations 4 g/2 mL, 4 mg, 4 mg/5 mL, 8 g/4 mL · Injection, Tablet, Syrup #4 CipronagCiprofloxacin 4presentations 200 mg, 250 mg, 500 mg · Infusion, Tablet #5 E-CipCiprofloxacin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Capsule #6 EkacinAmikacin 4presentations 100 mg, 250 mg, 50 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2323% of comparable products
Near market median52within ±5% of median
Above market median2626% of comparable products
Lowest-price equivalents11ties included
Company median price position 0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Entum 80 mgArtemether · Injection · 1mlx6's PKR 35.02/mL-80.2% vs market median Zyncilliin 250 mgAmpicillin · Injection · 10's PKR 29.67/vial/unit-53.8% vs market median Enmox 500 mgAmoxicillin · Capsule · 100's PKR 9.67/capsule-51.6% vs market median Engpan 500 mgMeropenem · Injection · 1's PKR 1,149.16/vial/unit-44.7% vs market median Enmox 250 mgAmoxicillin · Capsule · 100's PKR 6.50/capsule-40.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Macter International Limited248 products · 91 generics 32shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.239 products · 98 generics 30shared generics Bio-Labs(Pvt) Ltd234 products · 82 generics 30shared generics Nabiqasim Industries (Pvt) Ltd.,362 products · 118 generics 28shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 27shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 26shared generics
Regulatory & price activity

Observed database signals

Registration numbers102
Price-history records117
Products with price history6
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date27 Jul 2026
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

76 results
Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Colaite Colistimethate sodium 1 MIU IV injection 1's 092529 PKR 1,199.81 PKR 1,199.81/vial/unit Near median
Coliate Colistimethate sodium 4.5 MIU (≈150 mg colistin base activity) Injection 1's 116494 PKR 4,501.60 PKR 4,501.60/vial/unit Near median
Coliate Colistimethate sodium 2 MIU (≈68 mg colistin base activity) Injection 1's 115682 PKR 2,000.07 PKR 2,000.07/vial/unit Near median
E-Cip Ciprofloxacin 250 mg Capsule 10's 059760 PKR 263.01 PKR 26.30/capsule Near median
E-Cip Ciprofloxacin 250 mg/5 mL Suspension 60ml 067993 PKR 323.71 PKR 5.40/mL 6% above median
E-Cip Ciprofloxacin 125 mg/5 mL Suspension 60ml 067988 PKR 182.09 PKR 3.03/mL 14% below median
E-Cip Ciprofloxacin 500 mg Capsule 10's 059759 PKR 434.99 PKR 43.50/capsule 5% above median
E-Lev Levofloxacin 500 mg Capsule 10's 059762 PKR 667.65 PKR 66.77/capsule Near median
E-Lev Levofloxacin 250 mg Capsule 10's 059761 PKR 404.64 PKR 40.46/capsule Near median
Eaxiron Cefotaxime 0.25 g Injection Vial 032130 PKR 104.38 PKR 104.38/vial/unit Near median
Eaxiron Cefotaxime 1 g Injection Vial 032132 PKR 282.94 PKR 282.94/vial/unit Near median
Eaxiron Cefotaxime 0.5 g Injection Vial 032131 PKR 160.61 PKR 160.61/vial/unit Near median
Ekacin Amikacin 50 mg Injection 1's 047843 PKR 47.61 PKR 47.61/vial/unit Near median
Ekacin Amikacin 500 mg Injection 2mlx1's 046407 PKR 238.07 PKR 119.04/mL Near median
Ekacin Amikacin 100 mg Injection 2mlx1's 046408 PKR 78.09 PKR 39.05/mL Near median
Ekacin Amikacin 250 mg Injection 2mlx1's 046406 PKR 130.53 PKR 65.27/mL Near median
Encogyl Metronidazole (Benzoate) 500 mg Injection Vial 038370 PKR 127.61 PKR 127.61/vial/unit No comparator
Enfal Cefazolin 500 mg Injection Vial 040130 PKR 118.00 PKR 118.00/vial/unit Near median
Enfal Cefazolin 1 g Injection Vial 040131 PKR 209.50 PKR 209.50/vial/unit Near median
Enfal Cefazolin 250 mg Injection Vial 040129 PKR 78.67 PKR 78.67/vial/unit Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.